Sissoko Abdoulaye, Teguete Ibrahima, Djire Mohamed Yaya, Bagayoko Moussa Arouna, Diawara Boulaye, Kodio Amose, Diarra Siaka, Sidibe Fatoumata Matokoma, Ly Madani, Traore Sidy, Sangho Oumar, Togo Pierre A, Ouattara Moussa A, Traore Drissa, Sissoko Sara
Centre Hospitalier Mère enfant Le Luxembourg Bamako.
Centre Hospitalier Universitaire de Gabriel TOURE Bamako.
Mali Med. 2024;39(2):44-49.
Breast cancer is one of the main causes of morbidity and mortality in Africa and Mali and its prognosis remains serious with very low survival. We initiated this study to determine the overall and specific survival rate by treatment type.
This was a cross-sectional study from January 1, 2016 to October 31, 2021. It concerned all women who had been seen in the obstetric gynecology department of the teaching hospital Luxembourg in Bamako during the study period. We conducted a multivariate analysis of the factors influencing survival after logistic regression according to the Cox model.
We recorded 70 cases of breast cancer among 41613 gynecological consultations or 0.16%. Over the months there is a very rapid decrease in survival. The chemotherapy improves survival, surgery and radiotherapy greatly contribute to the improvement. Concerning hormone therapy, it protects subjects with a statistically significant probability (P<0,05).
Breast cancer survival remains very low in the department, the need for well-organized screening campaigns and early and multidisciplinary case management.
乳腺癌是非洲和马里发病和死亡的主要原因之一,其预后仍然严峻,生存率极低。我们开展这项研究以确定不同治疗类型的总体生存率和特定生存率。
这是一项从2016年1月1日至2021年10月31日的横断面研究。研究对象为研究期间在巴马科卢森堡教学医院妇产科就诊的所有女性。我们根据Cox模型进行逻辑回归后,对影响生存的因素进行了多变量分析。
在41613例妇科会诊病例中,我们记录到70例乳腺癌病例,占0.16%。几个月来,生存率急剧下降。化疗可提高生存率,手术和放疗对生存率的提高有很大贡献。关于激素治疗,它对患者有统计学上显著的保护作用(P<0.05)。
该科室的乳腺癌生存率仍然很低,需要开展组织良好的筛查活动以及进行早期多学科病例管理。